Detergent-Assisted Lp-PLA2 Assays for Accurate Activity Correlation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing immunoassays for Lp-PLA2 fail to accurately correlate with activity assays due to the enzyme's association with lipoprotein particles, leading to incomplete detection and poor correlation with activity measurements.

Innovation Solution

Employing specific amounts of detergents to liberate nearly all Lp-PLA2 molecules from lipoprotein particles, allowing for improved detection methods that correlate better with activity assays.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If immunoassays are used to measure Lp-PLA2 concentration without detergent treatment, then the assay procedure is simple, but the correlation with activity assays is poor

Engineering Contradiction:
Improvecorrelation with activity assaysVSAvoidassay procedure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by treating samples with detergent (such as CHAPS) before performing the immunoassay to liberate Lp-PLA2 from lipoprotein particles. This pre-treatment step ensures that the enzyme is fully accessible to antibodies, thereby improving correlation with activity assays while maintaining a relatively simple overall procedure

Inventive Principle:
Principle #10Preliminary action

2Measurement precision

If detergent is added to liberate Lp-PLA2 from lipoprotein particles, then detection accuracy improves, but sample handling complexity increases

Engineering Contradiction:
Improvedetection accuracyVSAvoidsample handling
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent applies parameter changes by optimizing detergent concentration (e.g., 0.1-1% CHAPS) and incubation conditions to achieve complete liberation of Lp-PLA2. This allows accurate detection while minimizing handling complexity through standardized, optimized protocols that balance effectiveness with operational simplicity

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If high amounts of detergent are used to ensure complete liberation of Lp-PLA2, then correlation with activity assays improves, but sample stability decreases

Engineering Contradiction:
Improvecorrelation coefficientVSAvoidsample stability
Core Design Contradiction:
Measurement precisionVSStability of the object's composition

Solution Approach 1:

The patent applies parameter changes by identifying and implementing optimal detergent concentrations (such as 0.1-1% CHAPS) that achieve complete Lp-PLA2 liberation while maintaining sample stability. This optimized parameter range ensures high correlation coefficients (r≥0.9) with activity assays without compromising sample integrity

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances the correlation between Lp-PLA2 concentration and activity measurements, achieving higher detection accuracy and improved sample handling with increased stability.

Implementation Method 1

employ amounts of detergent to liberate all or nearly all of the Lp-PLA2 molecules from associated lipoprotein particles

Methodology Applied
Scientific EffectMicelle formation: Microemulsion

Implementation Method 2

the first amount of detergent is sufficient such that: i) at least 95% of all of the Lp-PLA2 in the sample that is associated with the lipoprotein particles is liberated from the lipoprotein particles

Methodology Applied
Scientific EffectHydrophobic interaction disruption: Surfactant

Data Source

PatentUS20250237653A1Lp-PLA2 ASSAYS AND COMPOSITION WITH DETERGENT
Publication Date: 2025.07.24 CLEVELAND HEARTLAB
  • US20250237653A1 patent drawing
  • US20250237653A1 patent drawing
  • US20250237653A1 patent drawing

AI summary

Provided herein are methods, systems, and compositions for Lp-PLA2 detection assays that employ amounts of detergent to liberate all or nearly all of the Lp-PLA2 molecules from associated lipoprotein particles. In this regard, the true Lp-PLA2 concentration can be detected in a sample, which correlates better with known Lp-PLA2 activity assays.